SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is currently a focal point for investors as the community debates the stock's future amid volatility, with active discussion centered on new executive leadership hires and strategic partnerships aimed at regaining growth. While some retail investors express frustration over price performance and short-term trends, others are closely watching institutional moves and the potential for a recovery driven by its expanding role in programmatic Connected TV advertising.

Bonk is a dog-themed memecoin on the Solana blockchain, launched on Christmas Day 2022 to revitalize the Solana community following the FTX collapse. Created by an anonymous team of 22 Solana developers and builders, Bonk distributed 50% of its total 100 trillion token supply via airdrop to community members including NFT collectors, developers, and artists.   The project positions itself as "the first Solana dog coin for the people, by the people," explicitly rejecting venture capital backing in favor of grassroots community ownership. What sets Bonk apart from other memecoins is its combination of fair launch mechanics, extensive ecosystem integration, and active deflationary strategy.   Built on Solana, BONK benefits from fast transaction speeds and low fees that make it practical for everyday use. Native products include LetsBonk.fun (a memecoin launchpad that briefly became Solana's market leader in 2025, surpassing Pump.fun with over 78% market share), BonkSwap (a decentralized exchange) and BonkBot (a Telegram trading bot with built-in burn mechanics).   BONK is available across 10 blockchain networks and listed on major exchanges including Binance, Coinbase, Kraken, and Robinhood. Governance is handled by BonkDAO, which holds 15% of the token supply and makes decisions through on-chain voting.   The community has organized several major burn events, most notably the December 2024 BURNmas campaign that destroyed 1.69 trillion tokens worth over $50 million. In September 2025, Nasdaq-listed Safety Shot, Inc. formed BONK Holdings LLC and acquired over 2.5% of the circulating supply (valued at $55-63 million), making BONK one of the first memecoins to attract formal corporate treasury adoption. Core contributor Nom was appointed to Safety Shot's board, and the company holds a 10% revenue share in LetsBonk.fun.  As with all memecoins, BONK is a highly speculative asset with substantial volatility. Its value is primarily driven by community sentiment, social media momentum, and meme culture rather than traditional utility.   The anonymous team, while common in the memecoin space, means investors should exercise appropriate caution. Despite these risks, Bonk has established itself as one of the most successful community-driven tokens in the Solana ecosystem, approaching 1 million unique holders and expanding from a simple memecoin into meaningful DeFi infrastructure.

BONK

BONK is facing significant downward pressure and community frustration as investors grapple with a major treasury exploit, fueling widespread accusations of a scam and ongoing concerns about potential exchange delistings. Amidst this bearish sentiment and continued price decline, a vocal portion of the community remains divided, with some betting on a long-term recovery tied to a broader crypto market turnaround while others aggressively urge peers to cut their losses.

iShares Trust - iShares Biotechnology ETF

iShares Biotechnology ETF

Biotech is seeing renewed investor interest driven by a wave of strategic M&A activity and positive clinical trial readouts across the oncology and rare disease sectors. The community is actively tracking these catalysts while rotating capital into the iShares Biotechnology ETF as sentiment improves and rate outlooks become more favorable.

JetBlue Airways Corp. engages in the provision of air transportation services. Its brands include jetBlue, jetBlue Vacations, Paisly, and TrueBlue. It operates through the following geographic segments: Domestic and Canada, Caribbean and Latin America, and Atlantic. The company was founded by David Gary Neeleman in August 1998 and is headquartered in Long Island City, NY.

Jetblue Airways Corp

JetBlue is currently trending due to a surge in market speculation regarding potential merger and acquisition activity following reports of industry consolidation talks. Community discussions are highly polarized, balancing optimism around a buyout premium against concerns regarding the airline's significant debt load, exposure to elevated fuel costs, and the ongoing competitive pressure from other carriers.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan D. Green on March 5, 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

Lyft is garnering significant attention as investors speculate on a potential buyout given the company's attractive valuation, profitability, and active share repurchase program. The community is actively debating the stock's long-term growth potential and its high short interest, with many watching for a technical breakout fueled by strategic partnerships and expansion.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is experiencing heightened volatility and intense social media scrutiny as investors debate its role as a hedge against potential market instability amid escalating geopolitical tensions and ongoing debates over algorithmic market manipulation. Community discussion is sharply divided between those accumulating the stock as a long-term volatility play and those warning of the significant risks associated with the product's inherent decay and frequent reverse splits.

Themes ETF Trust - Leverage Shares 2X Short SPCX Daily ETF

Leverage Shares 2x Short SPCX Daily ETF 

SSPC is driving high-conviction trading activity as investors use the 2x inverse ETF to bet against SpaceX's valuation and market performance. Community discussion remains intensely focused on the stock's volatility, potential IPO lock-up expiration pressures, and the use of leveraged products to capture quick gains from the company's price swings.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is trending following the FDA's issuance of a Complete Response Letter for its Hunter syndrome therapy, RGX-121, which has sparked intense community debate regarding the company's future regulatory pathway and funding needs. Investors are now actively weighing these setbacks against the long-term potential of the firm's broader gene therapy pipeline, including ongoing late-stage data readouts.

Sony Group Corp. engages in the development, design, manufacture, and sale of electronic equipment, instruments, devices, game consoles, and software for consumers, professionals and industrial markets. It operates through the following segments: Game and Network Services, Music, Pictures, Entertainment Technology & Services, Imaging and Sensing Solutions, Financial Services, and Others. The Game and Network Services segment deals with gaming machines, software and network services. The Music segment produces and publishes music and provides image media platforms. The Pictures segment handles film production, television program creation, and media networks. The Home Entertainment and Sound segment offers LCD televisions, home audio, Blu-ray Disc players and recorders, and memory-based portable audio devices. The Imaging and Sensing Solutions segment includes the image sensors business. The Financial Services segment manages the life insurance and non-life insurance operations and banking business. The Others segment consists of various operating activities, including the disc manufacturing and recording media businesses. The company was founded by Akio Morita and Masaru Ibuka on May 7, 1946 and is headquartered in Tokyo, Japan.

Sony Group Corporation - ADR

Sony Group Corporation

Sony is facing intense backlash from gamers and regulatory scrutiny over its shift toward an all-digital ecosystem and the phase-out of physical media. Investors are also closely monitoring the company's struggle with underperforming live-service titles and the impact of these consumer-facing controversies on its long-term gaming revenue.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant market attention following the FDA approval of its tumor-only genomic testing platform, fueling optimism about its precision medicine and data monetization capabilities. Community discussions are centered on the stock's potential for a short squeeze, its role as a high-growth AI-in-healthcare play, and its expanding partnerships with major pharmaceutical firms.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


josephsimmonsiiiofficial

Joseph Simmons III